CompletedPhase 2NCT03482479
Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
Studying Vasculitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Pennsylvania
- Principal Investigator
- Peter A Merkel, MD, MPH, MD, MPHUniversity of Pennsylvania
- Intervention
- Naltrexone Hydrochloride(drug)
- Enrollment
- 60 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2025
Study locations (7)
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- University of Pittsburgh, Pittsburgh, Pennsylvania, United States
- University of Utah, Salt Lake City, Utah, United States
- St. Joseph's Healthcare, Hamilton, Ontario, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03482479 on ClinicalTrials.govOther trials for Vasculitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07278609The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic ConditionsMcGill University Health Centre/Research Institute of the McGill University Health Centre
- ENROLLING BY INVITATIONPHASE4NCT06763783Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic DiseasesRegion Skane
- RECRUITINGNCT06779799Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases (BAMBOO)University Hospital, Brest
- RECRUITINGNCT06698614MEMRI and Kidney DiseaseUniversity of Edinburgh
- RECRUITINGNCT06593041ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUSUniversity Hospital, Strasbourg, France
- RECRUITINGNCT06824714Prediction of Risk of Vascular Structural Damage in Patients With Large Vessel Vasculitis (LVV) Based on PET/MRA Image Evaluation SystemNanjing Medical University
- RECRUITINGNCT05734404Longitudinal Study for Central Nervous System VasculitisUniversity of Pennsylvania
- RECRUITINGNANCT05937880Leflunomide for Henoch-Schonlein PurpuraSun Yat-Sen Memorial Hospital of Sun Yat-Sen University